Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system-Reference-Cited by-同舟云学术

Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system

Published:2022-06-09 Issue:16 Volume:128 Page:3090-3098
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Knerr Sarah¹^ORCID,Guo Boya¹,Mittendorf Kathleen F.²^ORCID,Feigelson Heather Spencer³^ORCID,Gilmore Marian J.²,Jarvik Gail P.⁴,Kauffman Tia L.⁵,Keast Erin⁵,Lynch Frances L.⁵,Muessig Kristin R.²,Okuyama Sonia⁶,Veenstra David L.⁷,Zepp Jamilyn M.²,Goddard Katrina A. B.²,Devine Beth⁷

Affiliation:

1. School of Public Health University of Washington Washington Seattle USA

2. Department of Translational and Applied Genomics Center for Health Research, Kaiser Permanente Northwest Oregon Portland USA

3. Institute for Health Research Kaiser Permanente Denver Colorado USA

4. School of Medicine University of Washington Washington Seattle USA

5. Center for Health Research Kaiser Permanente Northwest Oregon Portland USA

6. Division of Oncology Denver Health and Hospital Authority Denver Colorado USA

7. The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, School of Pharmacy University of Washington Washington Seattle USA

Funder

National Institutes of Health

National Human Genome Research Institute

National Cancer Institute

National Institute on Minority Health and Health Disparities

National Comprehensive Cancer Network

Kaiser Permanente

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34349

Reference29 articles.

1. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer

2. WeissJM GuptaS BurkeCA et al. NCCN Guidelines Insights: genetic/familial high‐risk assessment: colorectal version 1.2021. Accessed June 3 2022.https://pubmed.ncbi.nlm.nih.gov/31487681/

3. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

4. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review

5. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects;Cancers;2024-06-25

2. Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico;JCO Global Oncology;2024-04

3. Knowledge, perceptions, attitudes, and barriers pertaining to genetic literacy among surgeons: a scoping review;Canadian Journal of Surgery;2024-03-19

4. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study;Cancer Medicine;2023-08-30

5. Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care;Biomolecules;2022-08-17